395822005: Papaveretum (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Hydrolase inhibitor\Phosphodiesterase inhibitor\Papaveretum (substance)
\Substance categorized by disposition\Receptor agonist\Opioid receptor agonist\Papaveretum (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Opioid receptor agonist\Papaveretum (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Analgesic (substance)\Papaveretum (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Alkaloid (substance)\Opium alkaloid (substance)\Papaveretum (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1469762014 Papaveretum (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1489463014 Papaveretum en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

831051000172110 papaveretum fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Papaveretum (substance)	Is a	Opium alkaloid (substance)	true	Inferred relationship	Some
Papaveretum (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Opioid receptor agonist (disposition)	true	Inferred relationship	Some
Papaveretum (substance)	Is a	Opioid receptor agonist	true	Inferred relationship	Some
Papaveretum (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Phosphodiesterase inhibitor (disposition)	true	Inferred relationship	Some
Papaveretum (substance)	Is a	Phosphodiesterase inhibitor	true	Inferred relationship	Some
Papaveretum (substance)	Is a	Analgesic (substance)	true	Inferred relationship	Some
Papaveretum (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Papaveretum [cns narcotic]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Papaveretum [anesthesia]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Papaveretum 10mg/1mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Papaveretum 20mg/1mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Papaveretum 15.4mg/hyoscine 400mcg injection solution 1mL ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Papaveretum BP 15.4mg/mL injection solution 1mL ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Papaveretum BP 7.7mg/mL injection solution 1mL ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Papaveretum injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Mixed opium alkaloids	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Product containing papaveretum and scopolamine hydrobromide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Product containing papaveretum (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Papaveretum (substance)	Inferred relationship	Some	1
Aspirin+papaveretum 500mg/7.71mg dispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Aspirin+papaveretum 500mg/10mg dispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Product containing aspirin and papaveretum (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Papaveretum (substance)	Inferred relationship	Some	2
Aspirin+papaveretum 500mg/10mg dispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Papaveretum 10mg/1mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Papaveretum 20mg/1mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Papaveretum (substance)	Inferred relationship	Some
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Papaveretum (substance)	Inferred relationship	Some	2
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection ampule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Papaveretum (substance)	Inferred relationship	Some	2
Product containing papaveretum and scopolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Papaveretum (substance)	Inferred relationship	Some	2
Product containing papaveretum and scopolamine in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Papaveretum (substance)	Inferred relationship	Some	2
Aspirin and papaveretum only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Papaveretum (substance)	Inferred relationship	Some	2
Papaveretum only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Papaveretum (substance)	Inferred relationship	Some	1
Product containing only papaveretum and scopolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Papaveretum (substance)	Inferred relationship	Some	2
Product containing only papaveretum and scopolamine in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Papaveretum (substance)	Inferred relationship	Some	2
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Papaveretum (substance)	Inferred relationship	Some	1
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Papaveretum (substance)	Inferred relationship	Some	1
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Papaveretum (substance)	Inferred relationship	Some	2
Product containing precisely papaveretum 15.4 milligram/1 milliliter and scopolamine hydrobromide 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Papaveretum (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1469762014	Papaveretum (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1489463014	Papaveretum	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
831051000172110	papaveretum	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module